BZ was previously reported to inhibit the growth of various human cancer cell lines in vitro by inhibiting nuclear factor κB (NFκB) activity via the reduction of a proteasomal degradation of inhibitor of NFκB [58,69,70]. Here, NFKB1 is linked to cancer.